HHS Recommends DEA Reschedule Cannabis to Schedule III

HHS Recommends DEA Reschedule Cannabis to Schedule III

Massively promising news for the cannabis industry today that many are calling historic: the Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA), recommending that cannabis be rescheduled from Schedule I to...
Payment Processing & CBD Products: What to Know

Payment Processing & CBD Products: What to Know

In the wake of the 2018 Farm Bill, the horizons of hemp-derived cannabis products expanded, offering nearly limitless opportunities for businesses and brands in the CBD industry to expand what they could offer to their customers. However, threading the path to...
The CBD Regulatory Environment in Europe: Part 2

The CBD Regulatory Environment in Europe: Part 2

This is Part Two of a four-part series discussing European cannabis regulations. Click here for Part One. Part Two analyzes the differences between the UK, the EU and the US. Part Three, coming next week, dives into dosage, approvals and more. Stay tuned for more. EU...
As Mastercard Exits Cannabis, There’s a Cash Opportunity

As Mastercard Exits Cannabis, There’s a Cash Opportunity

Late last month, Mastercard decided to halt their debit card transactions with cannabis dispensaries, notifying financial institutions and payment processors to stop processing purchases. This isn’t the first digital payment solution to swiftly exit the industry...